Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Jump-Start Your Search For Promising Trade Ideas With Barchart Premier’s "Top Stock Pick". FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:
Menu

Artara Therapeutics Inc (TARA)

Artara Therapeutics Inc (TARA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
Protara Therapeutics to Present Interim Data on TARA-002 for Non-Muscle Invasive Bladder Cancer at SUO Annual Meeting Quiver Quantitative, Inc. - Sat Nov 16, 3:12AM CST

Protara Therapeutics will present interim Phase 2 trial data for TARA-002 in NMIBC at the SUO meeting in December 2024.Quiver AI SummaryProtara Therapeutics, Inc. has announced that interim data from its...

TARA : 2.39 (+4.37%)
Protara Therapeutics to Present New Interim Data from Phase 2 ADVANCED-2 Trial of TARA-002 in Patients with NMIBC at the 25th Annual Meeting of the Society of Urologic Oncology GlobeNewswire - Fri Nov 15, 4:52PM CST

TARA : 2.39 (+4.37%)
Protara Therapeutics: Q3 Earnings Snapshot AP - Tue Nov 12, 7:08AM CST

Protara Therapeutics: Q3 Earnings Snapshot

TARA : 2.39 (+4.37%)
Protara Therapeutics Announces Third Quarter 2024 Financial Results and Provides a Business Update GlobeNewswire - Tue Nov 12, 7:00AM CST

TARA : 2.39 (+4.37%)
Protara Therapeutics to Present at the Guggenheim Inaugural Healthcare Innovation Conference GlobeNewswire - Wed Nov 6, 7:00AM CST

TARA : 2.39 (+4.37%)
Protara Therapeutics Granted FDA Fast Track Designation for Intravenous Choline Chloride for Patients Receiving Parenteral Support GlobeNewswire - Mon Oct 21, 7:00AM CDT

TARA : 2.39 (+4.37%)
Veeva: Fiscal Q2 Earnings Snapshot AP - Wed Aug 28, 3:18PM CDT

Veeva: Fiscal Q2 Earnings Snapshot

TARA : 2.39 (+4.37%)
Protara Therapeutics: Q2 Earnings Snapshot AP - Tue Aug 6, 7:11AM CDT

Protara Therapeutics: Q2 Earnings Snapshot

TARA : 2.39 (+4.37%)
Dollars and Wallets - Pile of Money with Hands
2 Stocks Under $10 Wall Street Says Are 'Strong Buys' Barchart - Tue May 28, 8:59AM CDT

You can spend less and earn significant returns with these two cheap stocks.

TARA : 2.39 (+4.37%)
$SPX : 5,969.34 (+0.35%)
OPT : 3.16 (+0.96%)
Protara Therapeutics Announces Second Quarter 2022 Financial Results and Business Overview Globe Newswire - Tue Aug 9, 2022

- Enrollment Progressing in Phase 1 ADVANCED-1 Study of TARA-002 for the Treatment of Non-Muscle Invasive Bladder Cancer - - Strong Cash, Cash Equivalents...

TARA : 2.39 (+4.37%)

Barchart Exclusives

3 High-Yielding Dividend Kings to Boost Your Income in 2025 and Beyond Barchart - Fri Nov 22, 6:00PM CST
These three high-quality companies are currently on sale, offering elevated yields that appeal to dividend growth investors. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar

[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot